“You're invited to a Rediscover MS Educational Event to gain a deeper understanding of the evolving science of multiple sclerosis (MS). The event will be hosted by a Sanofi Patient Education Manager” at Ruth’s Chris Steakhouse in Boise.
Sanofi is offering a steakhouse dinner on August 27 about “MS progression without relapses.” Some of us 208 MSers are cautiously optimistic about this talk. The science may be presented in a way that favors Sanofi’s drugs, but we’re all adults here.
Sanofi is the maker of Aubagio and Lemtrada and is working on Tolebrutinib, a non-relapsing secondary progressive MS medication.
